Category

Emerging field insights
17
Apr

Roche receives FDA Breakthrough Device Designation. Why is pTau-217 is becoming a hot biomarker for Alzheimer’s Disease?

April 17, 2024,
Read More
29
Mar

No longer eliminated, measle cases rise during post-COVID period

March 29, 2024
Read More
07
Mar

Tempus Labs Optimistic on MRD, Invests in and Assists Personalis in Commercialization

March 7, 2024
Read More
02
Mar

Despite being entangled in lawsuits, Genoscopy ventures into the inflammatory bowel disease detection field to break through early screening for colorectal cancer

March 2, 2024
Read More
19
Sep

Danaher Announces Cost-Price Sale of Tuberculosis Testing to Third-World Countries

September 19, 2023
Read More
12
Sep

Is multi-omics gaining prominence in the United States? NIH is funding it with $50.3 million

September 12, 2023
Read More
31
Aug

Dark horse in multi-cancer screening? Sword Edge targets Galleri!

August 31, 2023
Read More